Hermann Einsele - Selected Publications#

Since 2017 ISI “Highly Cited Researcher” in the category Clinical Medicine
H-Index: 113
Total publications: 1.841
Times Cited: 49.516

Hudecek M, Einsele H. Highjacking myeloma's niche with beefed-up CAR-Ts. Blood. 2022 Jun 30;139(26):3671-3672.

Seif M, et al. CAR T cells targeting <i>Aspergillus fumigatus</i> are effective at treating invasive pulmonary aspergillosis in preclinical models. Sci Transl Med. 2022 Sep 28;14(664).

Da Vià MC, et al. Homozygous BCMA gene deletion in response to anti-BCMA CAR T cells in a patient with multiple myeloma. Nat Med 20214):616-619.

Munshi NC, et al. Idecabtagene Vicleucel in Relapsed and Refractory Multiple Myeloma. N Engl J Med 2021;384:705-16.

Ataide MA, et al. BATF3 programs CD8+ T cell memory. Nat Immunol. 2020;21(11):1397-1407.

Gudipati V, et al. Inefficient CAR-proximal signaling blunts antigen sensitivity. Nat Immunol. 2020;21(8):848-85.

Topp MS, et al. Anti-B-Cell Maturation Antigen BiTE Molecule AMG 420 Induces Responses in Multiple Myeloma. J Clin Oncol 2020;38:775-83.

Mestermann K, et al. The tyrosine kinase inhibitor dasatinib acts as a pharmacologic on/off switch for CAR T cells. Sci Transl Med. 2019;11(499):eaau5907.

Querques I, et al. A highly soluble Sleeping Beauty transposase improves control of gene insertion. Nat Biotechnol 2019;37:1502-12.

Banaszek A, et al. On-target restoration of a split T cell-engaging antibody for precision immunotherapy. Nat Commun 2019;10:5387.